Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Neuronetics (STIM) Capital Expenditures (2017 - 2025)

Neuronetics (STIM) has disclosed Capital Expenditures for 9 consecutive years, with $216000.0 as the latest value for Q4 2025.

  • Quarterly Capital Expenditures rose 115.84% to $216000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $801000.0 through Dec 2025, up 6061.54% year-over-year, with the annual reading at $801000.0 for FY2025, 6061.54% up from the prior year.
  • Capital Expenditures for Q4 2025 was $216000.0 at Neuronetics, down from $579000.0 in the prior quarter.
  • The five-year high for Capital Expenditures was $1.2 million in Q3 2024, with the low at -$1.8 million in Q3 2022.
  • Average Capital Expenditures over 5 years is $177950.0, with a median of $295500.0 recorded in 2021.
  • The sharpest move saw Capital Expenditures tumbled 601.12% in 2022, then skyrocketed 693.92% in 2023.
  • Over 5 years, Capital Expenditures stood at -$125000.0 in 2021, then decreased by 18.4% to -$148000.0 in 2022, then surged by 693.92% to $879000.0 in 2023, then plummeted by 255.18% to -$1.4 million in 2024, then surged by 115.84% to $216000.0 in 2025.
  • According to Business Quant data, Capital Expenditures over the past three periods came in at $216000.0, $579000.0, and -$213000.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.